Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Promotion of Drugs for Off-label Uses

Promotion of Drugs for Off-label Uses This Viewpoint discussed drug companies’ disputed First Amendment rights and the US Food and Drug Administration’s enforcement authority. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Promotion of Drugs for Off-label Uses

JAMA Internal Medicine , Volume 177 (2) – Feb 7, 2017

Loading next page...
 
/lp/american-medical-association/promotion-of-drugs-for-off-label-uses-z0dnujqjet
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2016.7151
pmid
27820607
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint discussed drug companies’ disputed First Amendment rights and the US Food and Drug Administration’s enforcement authority.

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Feb 7, 2017

References